CalciMedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	9.15	5.53	1.33	4.76	4.93
Short-Term Investments	5.45	5.71	-	-	-
Cash & Short-Term Investments	14.6	11.24	1.33	4.76	4.93
Cash Growth	0.08%	746.87%	-72.13%	-3.39%	-
Prepaid Expenses	1.08	0.37	0.25	0.17	0.28
Restricted Cash	-	-	0.15	-	-
Total Current Assets	15.69	11.61	1.73	4.93	5.21
Property, Plant & Equipment	0.13	0.17	0.2	0.39	0.35
Long-Term Deferred Charges	-	-	-	1.11	-
Other Long-Term Assets	0.4	0.41	1.42	0.04	0.19
Total Assets	16.21	12.19	3.35	6.46	5.75
Accounts Payable	1.54	1.42	2.87	1.93	2.18
Accrued Expenses	2.25	2.61	1.72	1.83	2.63
Current Portion of Leases	-	-	-	0.16	-
Other Current Liabilities	-	-	0.2	-	0.16
Total Current Liabilities	3.78	4.03	4.78	3.92	4.97
Long-Term Leases	-	-	-	0.04	-
Other Long-Term Liabilities	3.4	-	7.8	4.42	0.81
Total Liabilities	7.18	4.03	12.58	8.38	5.78
Common Stock	0	0	0	0	0
Additional Paid-In Capital	164.53	154.22	40.4	39.89	37.77
Retained Earnings	-155.51	-146.06	-111.71	-103.88	-80.38
Comprehensive Income & Other	0	0	-	-	-
Total Common Equity	9.03	8.16	-71.3	-63.99	-42.61
Shareholders' Equity	9.03	8.16	-9.23	-1.92	-0.03
Total Liabilities & Equity	16.21	12.19	3.35	6.46	5.75
Total Debt	-	-	-	0.2	-
Net Cash (Debt)	14.6	11.24	1.33	4.57	4.93
Net Cash Growth	0.08%	746.87%	-70.94%	-7.35%	-
Net Cash Per Share	1.55	2.50	16.13	1.68	1.87
Filing Date Shares Outstanding	10.76	10.74	2.92	2.92	2.63
Total Common Shares Outstanding	10.76	5.75	2.92	2.73	2.63
Working Capital	11.9	7.58	-3.05	1.01	0.24
Book Value Per Share	0.84	1.42	-24.40	-23.47	-16.17
Tangible Book Value	9.03	8.16	-71.3	-63.99	-42.61
Tangible Book Value Per Share	0.84	1.42	-24.40	-23.47	-16.17
Machinery	-	-	-	0.24	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.